Skip to main content

Advertisement

We're creating a new version of this page. See preview

Volume 3 Supplement 1

ESICM LIVES 2015

  • Poster presentation
  • Open Access

Impact of periprocedural myocardial necrosis on short term clinical outcome

  • 1,
  • 1,
  • 1 and
  • 1
Intensive Care Medicine Experimental20153 (Suppl 1) :A954

https://doi.org/10.1186/2197-425X-3-S1-A954

  • Published:

Keywords

  • Cardiac biomarkers
  • PCI
  • MACENTRODUCTION

Objectives

To assess the prognostic value of periprocedural myocardial injury during elective in the early post intervention period.

Background

Elevations in the biochemical markers of myocardial damage are frequently detected after percutaneous coronary revascularization, but their clinical significance is still uncertain.

Methods

CK, CK-MB, and cTn I were prospectively assessed in 100 patients who underwent elective PCI during the period between Jan 2012 and Jan 2013.

Patients were subjected to history taking, routine laboratory investigations, electrocardiogram ( ECG), cardiac biomarkers assay, and Echocardiography pre and post PCI.

The primary end point was death, myocardial infarction or severe, recurrent ischemia at 90 days.

Results

Overall, 30 patients (30%) had elevated cardiac biomarkers after PCI. Elevated cardiac biomarkers were associated with significantly higher risks of the primary end point (MACE) in the early post intervention period (43.3% vs. 12.9%; p < 0.001) and a significantly higher risk of 3 months follow up MACE (66.7% vs. 14.3%; p < 0.001).

Elevation of cardiac biomarkers is more likely in older patients (p _ 0.034) , diabetics (96.7% vs. 11.4%; p < 0.001). , those with history of old MI(76.7% vs. 11.4%; p < 0.001). , and patients who had CHF (30% vs. 4.3%; p < 0.001) .while the gender , previous history of CVS ,COPD, and liver cirrhosis were non significant predictors of elevated cardiac biomarkers.

Conclusions

Elevated cardiac biomarkers, often observed after elective PCI in patients with IHD, is associated with worse early post intervention and 90-day clinical outcomes. This marker, therefore, is a useful prognostic indicator in such patients.

Authors’ Affiliations

(1)
Cairo University, Cairo, Egypt

Copyright

© Hamdi et al.; 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement